Business Plans

BioAbility provides complete business plans written, rewritten, or enhanced for your business with flexible financing options (see below) to decrease your up-front expenses.

BioAbility has been writing business and strategic plans for start-up companies, as well as updated plans for existing companies, for over a decade.  Our plans are:

·        Complete, turnkey documents developed in close conjunction with the company's principals

·        Suitable for use with investors and funding sources

·        Excellent road maps for business strategy

·        Inclusive of BioAbility's expert competitor analysis and market research studies

·        Extremely well written and carefully crafted

BioAbility's plans are individually tailored to each company, not written using a cookie-cutter formula.  They include market research and competitor analysis from BioAbility's Research Team of PhDs, MBAs, and MSLS information specialists and are augmented by BioAbility's affiliates as needed.   

Our business planning projects are headed by BioAbility President Mark D. Dibner whose scientific background, broad knowledge, connections in the biotechnology industry, and MBA in strategic planning contribute to his expertise.  Dr. Dibner has taught entrepreneurship and business planning courses at Duke University’s Fuqua School of Business and he was a Fellow at the Wharton School of Business. 

BioAbility's financial models, the heart of our plans are developed by Michael Henz, MBA.  Mike has strong business development and strategy formation background in the biotechnology and pharmaceutical industries. He has worked on many business plans in the biotechnology and life sciences arena.

We also bring in expert affiliates as needed to complete the plan. BioAbility's affiliates are top names in fields, such as biomanufacturing, valuation, regulatory planning, etc.

Deferred Cost Business Plans for Small Companies and New Entrepreneurs

BioAbility offers flexible financing options to small companies and entrepreneurs.  While BioAbility always strives to keep costs to its clients as low as possible, we understand that founders of new companies often have limited initial funds to start their company.  We have developed a plan to defer payment of part of our fee that should be very attractive to new companies.  With this option, we defer some of our up-front fees and take a small equity stake in the company.  The deferred payments are then paid with the first substantial funding of the company.  These are the same world-class complete business plans described above.  Contact Mark D. Dibner for details.